Literature DB >> 9555794

A randomized trial of acidified nitrite cream in the treatment of tinea pedis.

R Weller1, A D Ormerod, R P Hobson, N J Benjamin.   

Abstract

BACKGROUND: Nitric oxide is continually released from normal skin and has antimicrobial effects. An acidified nitrite cream releases supraphysiologic concentrations of nitric oxide and is fungicidal in vitro.
OBJECTIVE: The purpose of this study was to assess the efficacy of an acidified nitrite cream as treatment for tinea pedis.
METHODS: Sixty patients were recruited with both a clinical diagnosis of tinea pedis and hyphae identified on direct microscopy; they were randomly placed into an active group treated with twice-daily application of a mixture of 3% salicylic acid in aqueous cream and 3% nitrite in aqueous cream for 4 weeks and a control group treated with 3% salicylic acid in aqueous cream and aqueous cream alone. Nineteen patients completed the trial in the active group and 16 patients in the control group. Mycologic cure (negative results on microscopy and culture) and clinical improvement were measured at 0, 2, and 4 weeks and after a 2-week interval with no treatment.
RESULTS: At the end of the treatment period, 18 of the 19 patients in the active group were mycologically cured as were 11 of 16 in the control group (p = 0.042). Two weeks after the cessation of treatment, 13 of 19 patients in the active group were mycologically cured and 5 of 16 in the control group (p = 0.028). The initial clinical scores in the active and control groups were 8.1 and 8.19 (two-tailed p = 0.95). At 4 weeks they were 1.66 and 6.0 (two-tailed p = 0.002) and after 2 weeks with no treatment 1.45 and 7.4 (two-tailed p < 0.0002).
CONCLUSION: Acidified nitrite is effective therapy for tinea pedis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555794     DOI: 10.1016/s0190-9622(98)70117-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Biomedical evaluation of a novel nitrogen oxides releasing wound dressing.

Authors:  Rachna N Dave; Hiren M Joshi; Vayalam P Venugopalan
Journal:  J Mater Sci Mater Med       Date:  2012-09-22       Impact factor: 3.896

Review 2.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

3.  Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.

Authors:  R Phillips; O Adjei; S Lucas; N Benjamin; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  Sildenafil in the treatment of pressure ulcer: a randomised clinical trial.

Authors:  Shadi Farsaei; Hossein Khalili; Effat S Farboud; Zahra Khazaeipour
Journal:  Int Wound J       Date:  2013-06-04       Impact factor: 3.315

Review 5.  Topical treatments for fungal infections of the skin and nails of the foot.

Authors:  F Crawford; S Hollis
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 6.  The potential of nitric oxide releasing therapies as antimicrobial agents.

Authors:  David O Schairer; Jason S Chouake; Joshua D Nosanchuk; Adam J Friedman
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

7.  An observational prospective study of topical acidified nitrite for killing methicillin-resistant Staphylococcus aureus (MRSA) in contaminated wounds.

Authors:  Anthony D Ormerod; Amjad Aj Shah; Hong Li; Nigel B Benjamin; Gail P Ferguson; Carlo Leifert
Journal:  BMC Res Notes       Date:  2011-10-27

8.  Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream.

Authors:  A D Ormerod; M I White; S A Shah; N Benjamin
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

Review 9.  The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Authors:  Daniel J Hassett; Rhett A Kovall; Michael J Schurr; Nalinikanth Kotagiri; Harshita Kumari; Latha Satish
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

Review 10.  Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.

Authors:  Allison J Kutner; Adam J Friedman
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.